To compare the physiological and psychological effects of psilocin taken orally by pill or sublingually by dissolving a tablet under the tongue to those of psilocybin taken by pill in healthy adults.
Topic Healthy Subjects
Compound Psilocybin
Country United States of America
Visit trial
Status
Recruiting
Results Published
Start date
04 July 2022
End date
31 December 2024
Phase
Phase I
Design
Blinded
Type
Interventional
Generation
First
Participants
20
Sex
All
Age
25- 50
Therapy
Yes
Trial Details
To compare the physiological and psychological effects of psilocin taken orally by pill or sublingually by dissolving a tablet under the tongue to those of psilocybin taken by pill in healthy adults.Trial Number NCT05317689
Sponsors & Collaborators
University of California San FranciscoAt UCSF, there are two research teams dedicated to the study of psychedelics; the Neuroscape Psychedelic Division and the Translational Psychedelic Research Program.